World Journal of Pharmaceutical
and Medical Research

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Medical Research and Technology
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
ISSN 2455-3301
IMPACT FACTOR: 6.842

ICV : 78.6

World Journal of Pharmaceutical and Medical Research (WJPMR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Indian Science Publications , Cosmos Impact Factor , Research Bible, Fuchu, Tokyo. JAPAN , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , International Innovative Journal Impact Factor (IIJIF) , Scientific Journal Impact Factor (SJIF) , Global Impact Factor (In Process) , Digital Online Identifier-Database System (DOI-DS) , Science Library Index, Dubai, United Arab Emirates , Eurasian Scientific Journal Index (ESJI) , International Scientific Indexing, (ISI) UAE , IFSIJ Measure of Journal Quality , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

Abstract

A STUDY ON INFLAMMATORY MARKERS AND THE METABOLIC SYNDROME

Dr. Khushbakht Jabbar*, Dr. Muhammad Zaryab Haider and Dr. Zaryab Zaki

ABSTRACT

Background and objective: The metabolic syndrome has been conceptualized as a clustering of metabolic risk factors. Therefore, the main objective of the study is to analyse the relationship between inflammatory markers and the metabolic syndrome. Material and methods: This descriptive study was conducted in Post Graduate Medical Institute (PGMI), Lahore during October 2018 to March 2019. This study was done with the permission of ethical committee of hospital. The data was collected from 250 patients of both genders. The study groups were divided into three main parts. Results: The data was collected from 250 patients from which 150 females and 100 males. In the second group C-reactive protein is higher than in the first group with statistical significance (p = 0.02). Leukocytes have a less important value in establishing proinflammatory and cardiovascular risk contribution in patients with metabolic syndrome compared with C-reactive protein. Conclusion: It is concluded that obesity is the main factor of metabolic syndrome. Patients diagnosed with metabolic syndrome present an activated inflammatory status. Inflammatory syndrome is expressed according to the number of metabolic syndrome components.

[Full Text Article]    [Download Certificate]

Powered By WJPMR | All Right Reserved

WJPMR